State Of Wyoming Biogen Inc. Transaction History

State Of Wyoming

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $101,292 - $117,046	368 New	368 $104,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $138,842 - $168,696	-550 Reduced 60.24%	363 $100,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $132,194 - $182,284	679 Added 290.17%	913 $244,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $178,163 - $211,869	-950 Reduced 80.24%	234 $48,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $28,096 - $35,400	-145 Reduced 10.91%	1,184 $249,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $69,191 - $88,920	309 Added 30.29%	1,329 $319,000
Q3 2021 Feb 14, 2022	BUY	$282.99 - $369.05 $52,353 - $68,274	185 Added 22.16%	1,020 $288,000
Q3 2021 Feb 11, 2022	SELL	$282.99 - $369.05 $65,653 - $85,619	-232 Reduced 21.74%	835 $236,000
Q2 2021 Feb 14, 2022	BUY	$259.0 - $414.71 $24,605 - $39,397	95 Added 9.77%	1,067 $369,000
Q2 2021 Feb 11, 2022	BUY	$259.0 - $414.71 $210,308 - $336,744	812 Added 507.5%	972 $336,000
Q1 2021 Feb 08, 2022	BUY	$242.95 - $284.63 $38,872 - $45,540	160 New	160 $45,000

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.